RE: Looks more and more like takeover13 Apr 2021 20:47
Well, you kind of make my point to new shareholders.
1 It doesn't state in those policies that a company has to be operational on certain exchanges / bourses, -
I don't see AIM / EURONEXT GROWTH not applicable.
2 'he does have a duty to us share holders' - and he has recognised that, in that he says he wants to generate shareholder value.
You could argue he's done that in spades since January 2020, - I'm placing a tick in that box, - he's just not done it for new shareholders since January 2021.
OK so this is AIM, stuff goes up and down crazy sometimes, but the sp has to rise for shareholder value to improve.
He needs time to get to his Mid-Cap goal, and in 16 months he has launched many products, with breath-taking R & D and speed to market, and clearing debt.
Another example is the recently discussed genomic surveillance assay, or Variplex.
With the CE-IVD approved launch of this assay, the starting gun has been fired in the race to get SNPsig technology 'adopted' by commerce, industry and academia.
Recent posts have identified competing technologies from Thermo-Fisher, Perkin Elmer and Roche, (none of which have FDA, WHO or CE-IVD approval I believe).
Each will be trying to establish the primacy of their technology, much in the same way as Betamax, VHS and Phillips System 2000 fought to establish primacy for their video-tape products.
He's putting in maximum effort towards his mid-cap goal certainly.
But it's the unconventional 'no-hype here' way he does it that ticks off so many.
The aim of my post was to point out that NCYT share ownership comes with little sales / financial information available (bar what we can dig out and get Shaun to collate), and no media hype.
Videos are a luxury, - one of the last being a thank you to the staff for all the hard work they put in these last 16 months.
If you have bought NCYT shares, this is what you have bought into.
I think you have posted because what I have said dissuades certain types of new investors from investing.
I realise £12 is a long way from here Porky, but we need new investors to hear these things, else they are just going to become dissatisfied quickly and move on, some losing their shirt in the process.
If you have bought, you need to be prepared to hold.
Indeed, we have had a royal stuffing of late, but GM's way is to let the numbers do the talking, and with DHSC disagreement revealed, we will now see many product launches and the headway they make into their individual markets.
If GM plans for genomic surveillance come to fruition, we have a whole new income stream and long term market laid out that is ours to capture and profit from.
Note how long term that last line sounds, - another clue for new investors, and short termists.
Sign In
Follow the stocks
